×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IRD – opus genetics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IRD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/16
04:01 pm
ird
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12/11
07:00 am
ird
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference
Low
Report
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference
12/9
09:03 pm
ird
Opus Genetics (NASDAQ:IRD) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
Medium
Report
Opus Genetics (NASDAQ:IRD) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
12/9
07:00 am
ird
Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease
Medium
Report
Opus Genetics Announces Positive Recommendation from Independent Data Monitoring Committee for Phase 1/2 Trial in Best Disease
12/2
04:01 pm
ird
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12/2
06:16 am
ird
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Low
Report
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
11/29
01:34 am
ird
Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With “Overweight” Rating and $7 PT [Yahoo! Finance]
Medium
Report
Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With “Overweight” Rating and $7 PT [Yahoo! Finance]
11/26
06:43 am
ird
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Low
Report
Opus Genetics (NASDAQ:IRD) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/11
08:52 pm
ird
Form SCHEDULE 13D/A Opus Genetics, Inc. Filed by: Foundation Fighting Blindness Retinal Degeneration Fund
Low
Report
Form SCHEDULE 13D/A Opus Genetics, Inc. Filed by: Foundation Fighting Blindness Retinal Degeneration Fund
12/11
05:36 pm
ird
Form 4 Opus Genetics, Inc. For: Dec 09 Filed by: Foundation Fighting Blindness Retinal Degeneration Fund
Medium
Report
Form 4 Opus Genetics, Inc. For: Dec 09 Filed by: Foundation Fighting Blindness Retinal Degeneration Fund
11/12
07:24 am
ird
Form 10-Q Opus Genetics, Inc. For: Sep 30
Low
Report
Form 10-Q Opus Genetics, Inc. For: Sep 30
11/12
07:07 am
ird
Form 8-K Opus Genetics, Inc. For: Nov 12
Low
Report
Form 8-K Opus Genetics, Inc. For: Nov 12
11/6
04:32 pm
ird
Form 8-K Opus Genetics, Inc. For: Nov 05
Medium
Report
Form 8-K Opus Genetics, Inc. For: Nov 05
11/6
08:25 am
ird
Form 8-K Opus Genetics, Inc. For: Nov 06
Medium
Report
Form 8-K Opus Genetics, Inc. For: Nov 06
11/6
08:24 am
ird
Form FWP Opus Genetics, Inc. Filed by: Opus Genetics, Inc.
Medium
Report
Form FWP Opus Genetics, Inc. Filed by: Opus Genetics, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: